News
Life Sciences IPOs Have Biggest Month in 13 Years, Burrill & Company says June 04, 2013 | Press Release
Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
See all NewsVenture Capital

SCYNEXIS is a chemistry-focused drug discovery and development company with its headquarters located in Research Triangle Park, North Carolina. SCYNEXS' goal, from concept to clinic, is to deliver effective and innovative drug pipeline solutions to our pharmaceutical partners.
For more information, please visit

